XSPRAY PHARMA AB NPVXSPRAY PHARMA AB NPVXSPRAY PHARMA AB NPV

XSPRAY PHARMA AB NPV

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
Revenue estimate
Market capitalization
‪1.27 B‬SEK
−7.20SEK
‪−179.67 M‬SEK
‪19.93 M‬
Beta (1Y)
1.49

About XSPRAY PHARMA AB

CEO
Per Andersson
Headquarters
Solna
Employees (FY)
26
Founded
2003
ISIN
SE0009973563
FIGI
BBG00JSC0XV4
Xspray Pharma AB is a pharmaceutical company, which develops and produces product candidates in clinical development phase. It uses its innovative, patented technology to develop amorphous product candidates that are improved versions of marketed drugs, primarily protein kinase inhibitors, for the treatment of cancer. Its product portfolio includes candidates based on the firm's HyNap platform: Dasynoc, HyNap-Nilo, and HyNap-Sora. The company was founded by Mustafa Demirbüker and Håkan Nykvist in November 2003 and is headquartered in Solna, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0GHZ is 44.00 SEK — it has increased by 0.23% in the past 24 hours. Watch XSPRAY PHARMA AB NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange XSPRAY PHARMA AB NPV stocks are traded under the ticker 0GHZ.
XSPRAY PHARMA AB NPV is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
0GHZ stock is 2.50% volatile and has beta coefficient of 1.49. Track XSPRAY PHARMA AB NPV stock price on the chart and check out the list of the most volatile stocks — is XSPRAY PHARMA AB NPV there?
Yes, you can track XSPRAY PHARMA AB NPV financials in yearly and quarterly reports right on TradingView.
0GHZ net income for the last quarter is ‪−54.50 M‬ SEK, while the quarter before that showed ‪−38.94 M‬ SEK of net income which accounts for −39.94% change. Track more XSPRAY PHARMA AB NPV financial stats to get the full picture.
Today XSPRAY PHARMA AB NPV has the market capitalization of ‪1.28 B‬, it has increased by 1.40% over the last week.
No, 0GHZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0GHZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade XSPRAY PHARMA AB NPV stock right from TradingView charts — choose your broker and connect to your account.
0GHZ reached its all-time high on Jan 4, 2021 with the price of 194.00 SEK, and its all-time low was 29.40 SEK and was reached on Jul 25, 2023. View more price dynamics on 0GHZ chart.
See other stocks reaching their highest and lowest prices.
As of May 3, 2024, the company has 26.00 employees. See our rating of the largest employees — is XSPRAY PHARMA AB NPV on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So XSPRAY PHARMA AB NPV technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating XSPRAY PHARMA AB NPV stock shows the neutral signal. See more of XSPRAY PHARMA AB NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.